Overcoming hypoxia to improve tissue‐engineering approaches to regenerative medicine

The current clinical successes of tissue engineering are limited primarily to low‐metabolism, acellular, pre‐vascularized or thin tissues. Mass transport has been identified as the primary culprit, limiting the delivery of nutrients (such as oxygen and glucose) and removal of wastes, from tissues deep within a cellular scaffold. While strategies to develop sufficient vasculature to overcome hypoxia in vitro are promising, inconsistencies between the in vitro and the in vivo environments may still negate the effectiveness of large‐volume tissue‐engineered scaffolds. While a common theme in tissue engineering is to maximize oxygen supply, studies suggest that moderate oxygenation of cellular scaffolds during in vitro conditioning is preferable to high oxygen levels. Aiming for moderate oxygen values to prevent hypoxia while still promoting angiogenesis may be obtained by tailoring in vitro culture conditions to the oxygen environment the scaffold will experience upon implantation. This review discusses the causes and effects of tissue‐engineering hypoxia and the optimization of oxygenation for the minimization of in vivo hypoxia. Copyright © 2012 John Wiley & Sons, Ltd.